FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib

Fibroblast growth factor receptor (FGFR) gene alterations are relatively frequent in lung squamous cell carcinoma (LSCC) and are a potential targets for therapy with FGFR inhibitors. However, little is known regarding the clinicopathologic features associated with FGFR alterations. The angiokinase i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hibi, Masaaki, Kaneda, Hiroyasu, Tanizaki, Junko, Sakai, Kazuko, Togashi, Yosuke, Terashima, Masato, De Velasco, Marco Antonio, Fujita, Yoshihiko, Banno, Eri, Nakamura, Yu, Takeda, Masayuki, Ito, Akihiko, Mitsudomi, Tetsuya, Nakagawa, Kazuhiko, Okamoto, Isamu, Nishio, Kazuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132273/
https://www.ncbi.nlm.nih.gov/pubmed/27581340
http://dx.doi.org/10.1111/cas.13071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132273/
https://www.ncbi.nlm.nih.gov/pubmed/27581340
http://dx.doi.org/10.1111/cas.13071

Ejemplares similares